XENE R&D Expenses
Xenon Pharmaceuticals Inc · R&D Expenses
XENE R&D Expenses
Latest reported$352.49Mperiod ending
XENE TTM R&D Expenses ($12.30M → $352.49M)
TTM R&D Expenses
High-resolution chart · PNG
XENE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 352,485,000 | |
| 328,246,000 | |
| 300,938,000 | |
| 272,711,000 | |
| 252,627,000 | |
| 227,344,000 | |
| 210,394,000 | |
| 191,998,000 | |
| 177,908,000 | |
| 172,246,000 | |
| 167,512,000 | |
| 161,266,000 | |
| 147,817,000 | |
| 125,923,000 | |
| 105,767,000 | |
| 92,824,000 | |
| 82,284,000 | |
| 78,515,000 | |
| 75,463,000 | |
| 68,543,000 | |
| 62,697,000 | |
| 55,040,000 | |
| 50,523,000 | |
| 47,308,000 | |
| 44,014,000 | |
| 41,499,000 | |
| 38,845,000 | |
| 33,499,000 | |
| 29,988,000 | |
| 27,191,000 | |
| 23,634,000 | |
| 23,625,000 | |
| 24,549,000 | |
| 25,250,000 | |
| 25,573,000 | |
| 23,572,000 | |
| 22,373,000 | |
| 21,367,000 | |
| 19,828,000 | |
| 19,695,000 | |
| 17,523,000 | |
| 16,089,000 | |
| 15,152,000 | |
| 14,342,000 | |
| 13,765,000 | |
| 12,662,000 | |
| 11,768,000 | |
| 11,058,000 | |
| 10,419,000 | |
| 11,344,500 | |
| 12,303,000 | |
| 12,402,500 | |
| 12,668,000 |